Gut microbiota‐derived synbiotic formula (SIM01) as a novel

G-NiiB Immunity+ Formula SIM01

Gut microbiota in COVID-19: key microbial changes, potential mechanisms and clinical applications

Characterization of the Intestinal Microbiome in Healthy Adults over Sars-Cov-2 Vaccination

Viruses, Free Full-Text

The effect of synbiotic adjunct therapy on clinical and paraclinical outcomes in hospitalized COVID‐19 patients: A randomized placebo‐controlled trial - Vaezi - 2023 - Journal of Medical Virology - Wiley Online Library

G-NiiB Immunity+ Formula SIM01

Gut microbiota‐derived synbiotic formula (SIM01) as a novel adjuvant therapy for COVID‐19: An open‐label pilot study - Zhang - 2022 - Journal of Gastroenterology and Hepatology - Wiley Online Library

Multifaceted role of synbiotics as nutraceuticals, therapeutics and carrier for drug delivery - ScienceDirect

IJMS, Free Full-Text

Siew NG, Professor (Full), MBBS (Lon), FRCP (Lond, Edin), PhD (Lond), FHKCP, FHKAM (Med), The Chinese University of Hong Kong, Hong Kong, CUHK, Department of Medicine and Therapeutics

Gut microbiota in COVID-19: key microbial changes, potential mechanisms and clinical applications